PRPH שווי מלא של הפעילות העסקית ProPhase Labs Corp

ProPhase Labs, Inc. (PRPH) leverages the synergy between specialized geneticists and diagnostic experts to create an environment for rapid career growth. The business is based on moderately cyclical laboratory services and the sale of dietary supplements, where an autumn peak offsets the volatility in testing demand. The current metric stands at 9.45. This price action chart confirms the company's macro resilience, which depends on the rollout of new products and the success of clinical trials.

Investors are seeking a fundamental anchor in the business resilience of ProPhase Labs, Inc. (PRPH), yet reliance on post-pandemic diagnostic demand and genomics expenditures create risks of profit degradation. The enterprise value reflects the total cost of the asset by summing market capitalization and net debt. The current value of 9.45 allows for an assessment of the actual costs of acquiring the company. A decline in this indicator often signals a loss of liquidity and market attractiveness.